What drives country differences in cost of Alzheimer's Disease? An explanation from resource use in the GERAS Study

Autor: Reed, C1, Happich, M2, Argimon, Jm3, Haro, Jm4, Wimo, A5, 6, Bruno, Giuseppe, Dodel, R8, Jones, Rw9, Vellas, B10, Author information 1 Eli Lilly, Belger M. 1., Company, Limited, Lilly Research Centre, Windlesham, 2 Lilly Deutschland GmbH, U. K., Bad, Homburg, 3 Divisió d'avaluació, G. e. r. m. a. n. y., Servei Català de la Salut, Barcelona, 4 Parc Santari Sant Joan de Déu, S. p. a. i. n., Cibersam, Universitat de Barcelona, Sant Boi de Llobregat, 5 KI Division of Neurogeriatrics, S. p. a. i. n., Department of Neurobiology, Care, Sciences, Society, Karolinska, Institute, Stockholm, 6 Centre for Research, S. w. e. d. e. n., Development, Uppsala University/Region of Gavleborg, Gävle, 7 Clinica della Memoria, S. w. e. d. e. n., Department of Neurology, Psychiatry, University of Rome Sapienza, Rome, 8 Department of Neurology, I. t. a. l. y., Philipps, University, Marburg, 9 RICE, G. e. r. m. a. n. y., The RICE Centre, Royal United Hospital, Bath, 10 Gerontopole, U. K., Alzheimer's Disease Research, Clinical, Care, Inserm, 1027, Toulouse University Hospital, Toulouse, France

Publikováno v: Dipòsit Digital de la UB
Universidad de Barcelona
Recercat. Dipósit de la Recerca de Catalunya
instname

BACKGROUND: Country differences in resource use and costs of Alzheimer's disease (AD) may be driven by differences in health care systems and resource availability. OBJECTIVE: To compare country resource utilization drivers of societal costs for AD d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44e102a79e279aa80b7033f5dfcf303f
http://hdl.handle.net/2445/123378

Glutamatergic dysfunction leads to a hyper-dopaminergic phenotype through deficits in short-term habituation: a mechanism for aberrant salience.

Autor: Panayi MC; Department of Experimental Psychology, University of Oxford, Tinsley Building, Mansfield Road, Oxford, OX1 3SR, UK. marios.panayi@nih.gov.; Wellcome Centre for Integrative Neuroimaging, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DU, UK. marios.panayi@nih.gov.; National Institute on Drug Abuse Intramural Research Program, 251 Bayview Blvd., Baltimore, MD, 21224, USA. marios.panayi@nih.gov., Boerner T; Department of Experimental Psychology, University of Oxford, Tinsley Building, Mansfield Road, Oxford, OX1 3SR, UK., Jahans-Price T; Department of Experimental Psychology, University of Oxford, Tinsley Building, Mansfield Road, Oxford, OX1 3SR, UK.; Wellcome Centre for Integrative Neuroimaging, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DU, UK., Huber A; Department of Psychiatry, University of Oxford, Oxford, OX3 7JX, UK., Sprengel R; Max Planck Institute for Medical Research, Institute for Anatomy and Cell Biology, Heidelberg University, Heidelberg, Germany., Gilmour G; Lilly Centre for Cognitive Neuroscience, Discovery Biology, Lilly Research Centre, Lilly UK, Windlesham, Surrey, UK., Sanderson DJ; Department of Psychology, Durham University, Durham, UK., Harrison PJ; Department of Psychiatry, University of Oxford, Oxford, OX3 7JX, UK., Walton ME; Department of Experimental Psychology, University of Oxford, Tinsley Building, Mansfield Road, Oxford, OX1 3SR, UK. mark.walton@psy.ox.ac.uk.; Wellcome Centre for Integrative Neuroimaging, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DU, UK. mark.walton@psy.ox.ac.uk., Bannerman DM; Department of Experimental Psychology, University of Oxford, Tinsley Building, Mansfield Road, Oxford, OX1 3SR, UK. david.bannerman@psy.ox.ac.uk.

Publikováno v: Molecular psychiatry [Mol Psychiatry] 2023 Feb; Vol. 28 (2), pp. 579-587. Date of Electronic Publication: 2022 Dec 02.

Research Recommendations Following the Discovery of Pain Sensitizing IgG Autoantibodies in Fibromyalgia Syndrome.

Autor: Goebel A; Institute of Life Course and Medicine Sciences, Pain Research Institute, University of Liverpool, and Walton Centre NHS Foundation Trust, Liverpool, UK., Andersson D; Institute of Psychiatry, Psychology and Neuroscience, Wolfson Centre for Age Related Disease, King's College, London, UK., Barker C; Lancashire and South Cumbria NHS Foundation Trust, UK., Basu N; Institute of Infection, Immunity & Inflammation, University of Glasgow, Glasgow, UK., Bullock C; Versus Arthritis, Copeman House, St Mary's Court, St Mary's Gate, Chesterfield, UK., Bevan S; Institute of Psychiatry, Psychology and Neuroscience, Wolfson Centre for Age Related Disease, King's College, London, UK., Bashford-Rogers RJM; Wellcome Centre for Human Genetics, Oxford, UK., Choy E; CREATE Centre, Division of Infection and Immunity, Cardiff University, UK., Clauw D; Anesthesiology, Medicine (Rheumatology) and Psychiatry University of Michigan, Ann Arbor, Michigan, USA., Dulake D; Patient Representative, Relative, Mansfield, UK., Dulake R; Patient Representative, Relative, Mansfield, UK., Flor H; Institute of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Glanvill M; Patient Representative, Liverpool, UK., Helyes Z; Department of Pharmacology and Pharmacotherapy, Medical School & Szentágothai Research Centre, University of Pécs, Pécs, Hungary., Irani S; Oxford Autoimmune Neurology Group, John Radcliffe Hospital, University of Oxford, Oxford, UK., Kosek E; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden., Laird J; Eli Lilly and Company, Pain & Neurodegeneration Therapeutic Area, Lilly Research Centre, Windlesham, Surrey, UK., MacFarlane G; Epidemiology Group, Aberdeen, Scotland., McCullough H; Institute of Life Course and Medicine Sciences, Pain Research Institute, University of Liverpool, Liverpool, UK., Marshall A; Institute of Life Course and Medicine Sciences, Pain Research Institute, University of Liverpool, and Walton Centre NHS Foundation Trust, Liverpool, UK., Moots R; Faculty of Health Social Care and Medicine, Edge Hill University, Liverpool, UK.; Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK., Perrot S; Pain Center, Cochin Hospital, Paris University, Paris, France., Shenker N; Rheumatology Research Unit, Addenbrooke's Hospital, Cambridge, UK., Sher E; Eli Lilly and Company, Pain & Neurodegeneration Therapeutic Area, Lilly Research Centre, Windlesham, Surrey, UK., Sommer C; Department of Neurology, University Hospital Würzburg, Germany., Svensson CI; Department of Physiology and Pharmacology, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden., Williams A; Health Psychology, UCL Research Department of Clinical, Educational & Health Psychology, University College London, UK., Wood G; Cambridge Institute for Medical Research, Cambridge, UK., Dorris ER; School of Medicine, University College Dublin, Ireland.

Publikováno v: Pain medicine (Malden, Mass.) [Pain Med] 2022 May 30; Vol. 23 (6), pp. 1084-1094.

Transition-Metal-Mediated Chemo- and Stereoselective Total Synthesis of (-)-Galanthamine.

Autor: Miller IR; School of Chemistry, University of Southampton, Highfield, Southampton SO17 1BJ, U.K., McLean NJ; School of Chemistry, University of Southampton, Highfield, Southampton SO17 1BJ, U.K., Moustafa GAI; School of Chemistry, University of Southampton, Highfield, Southampton SO17 1BJ, U.K., Ajavakom V; School of Chemistry, University of Southampton, Highfield, Southampton SO17 1BJ, U.K., Kemp SC; School of Chemistry, University of Southampton, Highfield, Southampton SO17 1BJ, U.K., Bellingham RK; Chemical Development, Glaxo SmithKline Pharmaceuticals, The Old Powder Mills, Leigh, Tonbridge, Kent TN11 9AN, U.K., Camp NP; Eli Lilly Research Centre, Erl Wood Manor, Sunninghill Road, Windlesham, Surrey GU20 6PH, U.K., Brown RCD; School of Chemistry, University of Southampton, Highfield, Southampton SO17 1BJ, U.K.

Publikováno v: The Journal of organic chemistry [J Org Chem] 2022 Jan 21; Vol. 87 (2), pp. 1325-1334. Date of Electronic Publication: 2022 Jan 10.

Genetic underpinnings of sociability in the general population.

Autor: Bralten J; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.; Donders Institute for Brain, Cognition and Behaviour, Nijmegen, The Netherlands., Mota NR; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.; Donders Institute for Brain, Cognition and Behaviour, Nijmegen, The Netherlands., Klemann CJHM; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands., De Witte W; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands., Laing E; Lilly Research Centre, Eli Lilly and Company, Surrey, UK., Collier DA; Lilly Research Centre, Eli Lilly and Company, Surrey, UK., de Kluiver H; Department of Psychiatry, Amsterdam University Medical Center/GGZ in Geest, Vrije Universiteit, Amsterdam, The Netherlands., Bauduin SEEC; Department of Psychiatry, Leiden Institute for Brain and Cognition/Psychiatric Neuroimaging, Leiden University Medical Center, Leiden, The Netherlands., Arango C; Institute of Psychiatry and Mental Health, Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón School of Medicine, Universidad Complutense, CIBERSAM, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain., Ayuso-Mateos JL; Department of Psychiatry, Instituto de Investigación Sanitaria La Princesa (IIS-IP), CIBERSAM, Universidad Autónoma de Madrid, Madrid, Spain., Fabbri C; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.; Department of Biomedical and NeuroMotor Sciences, University of Bologna, Bologna, Italy., Kas MJ; Groningen Institute for Evolutionary Life Sciences, University of Groningen, Groningen, The Netherlands., van der Wee N; Department of Psychiatry, Leiden Institute for Brain and Cognition/Psychiatric Neuroimaging, Leiden University Medical Center, Leiden, The Netherlands., Penninx BWJH; Department of Psychiatry, Amsterdam University Medical Center/GGZ in Geest, Vrije Universiteit, Amsterdam, The Netherlands., Serretti A; Department of Biomedical and NeuroMotor Sciences, University of Bologna, Bologna, Italy., Franke B; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.; Donders Institute for Brain, Cognition and Behaviour, Nijmegen, The Netherlands.; Department of Psychiatry, Radboud University Medical Center, Nijmegen, The Netherlands., Poelmans G; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands. Geert.Poelmans@radboudumc.nl.

Publikováno v: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [Neuropsychopharmacology] 2021 Aug; Vol. 46 (9), pp. 1627-1634. Date of Electronic Publication: 2021 May 30.